Photochemotherapy of vitiligo. Use of orally administered psoralens and a high-intensity long-wave ultraviolet light system
- 1 November 1976
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 112 (11) , 1531-1534
- https://doi.org/10.1001/archderm.112.11.1531
Abstract
A new light source that provides high-intensity UV light (UVA) (300-400 nm) to the entire body surface makes orally administered psoralen treatment of vitiligo with an artificial light practical. In the 26 patients studied, the degree of repigmentation with either trioxsalen (TMP) or methoxsalen (8-MOP) and high intensity UVA was at least as great as that with the same oral agents and sunlight. With artifical UVA and similar treatment conditions, the 2 psoralen derivatives were compared in the treatment of vitiligo; TMP stimulated repigmentation as well as 8-MOP and caused fewer side effects.This publication has 3 references indexed in Scilit:
- Psoralen phototherapeutic agentsJAMA, 1967
- Hydroquinone and psoralens in the therapy of hypermelanosis and vitiligoArchives of Dermatology, 1966
- Clinical and Experimental Studies with 8-Methoxypsoralen in Vitiligo1Journal of Investigative Dermatology, 1953